BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28182203)

  • 1. CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study.
    Yuan JM; Nelson HH; Carmella SG; Wang R; Kuriger-Laber J; Jin A; Adams-Haduch J; Hecht SS; Koh WP; Murphy SE
    Carcinogenesis; 2017 Apr; 38(4):411-418. PubMed ID: 28182203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study.
    Yuan JM; Nelson HH; Butler LM; Carmella SG; Wang R; Kuriger-Laber JK; Adams-Haduch J; Hecht SS; Gao YT; Murphy SE
    Int J Cancer; 2016 May; 138(9):2161-71. PubMed ID: 26662855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study.
    Park SL; Murphy SE; Wilkens LR; Stram DO; Hecht SS; Le Marchand L
    PLoS One; 2017; 12(5):e0178435. PubMed ID: 28542511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine Metabolism and Smoking: Ethnic Differences in the Role of P450 2A6.
    Murphy SE
    Chem Res Toxicol; 2017 Jan; 30(1):410-419. PubMed ID: 28092945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo.
    Sellers EM; Ramamoorthy Y; Zeman MV; Djordjevic MV; Tyndale RF
    Nicotine Tob Res; 2003 Dec; 5(6):891-9. PubMed ID: 14668073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An association of CYP2A6 genotype and smoking topography.
    Strasser AA; Malaiyandi V; Hoffmann E; Tyndale RF; Lerman C
    Nicotine Tob Res; 2007 Apr; 9(4):511-8. PubMed ID: 17454707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
    Derby KS; Cuthrell K; Caberto C; Carmella S; Murphy SE; Hecht SS; Le Marchand L
    Int J Cancer; 2009 Nov; 125(10):2418-24. PubMed ID: 19598261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer.
    Derby KS; Cuthrell K; Caberto C; Carmella SG; Franke AA; Hecht SS; Murphy SE; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3526-35. PubMed ID: 19029401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.
    Anderson KE; Carmella SG; Ye M; Bliss RL; Le C; Murphy L; Hecht SS
    J Natl Cancer Inst; 2001 Mar; 93(5):378-81. PubMed ID: 11238699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer.
    Yuan JM; Butler LM; Stepanov I; Hecht SS
    Cancer Res; 2014 Jan; 74(2):401-11. PubMed ID: 24408916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.
    Hecht SS; Carmella SG; Chen M; Dor Koch JF; Miller AT; Murphy SE; Jensen JA; Zimmerman CL; Hatsukami DK
    Cancer Res; 1999 Feb; 59(3):590-6. PubMed ID: 9973205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).
    Ter-Minassian M; Asomaning K; Zhao Y; Chen F; Su L; Carmella SG; Lin X; Hecht SS; Christiani DC
    Int J Cancer; 2012 Mar; 130(6):1338-46. PubMed ID: 21544809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
    Wang H; Tan W; Hao B; Miao X; Zhou G; He F; Lin D
    Cancer Res; 2003 Nov; 63(22):8057-61. PubMed ID: 14633739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity.
    Park SL; Tiirikainen MI; Patel YM; Wilkens LR; Stram DO; Le Marchand L; Murphy SE
    Carcinogenesis; 2016 Mar; 37(3):269-279. PubMed ID: 26818358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Muscat JE; Djordjevic MV; Colosimo S; Stellman SD; Richie JP
    Cancer; 2005 Apr; 103(7):1420-6. PubMed ID: 15726545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of watercress consumption on urinary metabolites of nicotine in smokers.
    Hecht SS; Carmella SG; Murphy SE
    Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):907-13. PubMed ID: 10548320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by Moldovan children.
    Stepanov I; Hecht SS; Duca G; Mardari I
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):7-11. PubMed ID: 16434579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk.
    Patel YM; Park SL; Han Y; Wilkens LR; Bickeböller H; Rosenberger A; Caporaso N; Landi MT; Brüske I; Risch A; Wei Y; Christiani DC; Brennan P; Houlston R; McKay J; McLaughlin J; Hung R; Murphy S; Stram DO; Amos C; Le Marchand L
    Cancer Res; 2016 Oct; 76(19):5768-5776. PubMed ID: 27488534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cruciferous vegetable consumption on urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in singapore chinese.
    Hecht SS; Carmella SG; Kenney PM; Low SH; Arakawa K; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):997-1004. PubMed ID: 15184256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer.
    Tanner JA; Henderson JA; Buchwald D; Howard BV; Nez Henderson P; Tyndale RF
    Pharmacogenet Genomics; 2017 May; 27(5):169-178. PubMed ID: 28181923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.